• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

    3.360 -0.230 (-6.41%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,102,300
    Open 3.580
    Bid (Size) 3.260 (100)
    Ask (Size) 3.400 (200)
    Prev. Close 3.590
    Today's Range 3.350 - 3.595
    52wk Range 3.350 - 8.740
    Shares Outstanding 14,508,063
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    UNCY DEADLINE: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
    From Levi & Korsinsky, LLP
    Via ACCESS Newswire
    News headline image
    Kaplan Fox Alerts Investors to an Upcoming Deadline of November 2, 2026 in the Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Securities Class Action
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit

    Performance

    52-Week Range 61.6% below 52-week high
    3.360
    3.3552W Low 8.7452W High
    1 Week 18.2% below 1-week high
    3.351W Low 4.111W High

    Unicycive Therapeutics, Inc. - Common Stock (UNCY) traded between $3.35 and $8.74 over the past 52 weeks and last traded at $3.36, 61.6% below its 52-week high. Over the past week it ranged between $3.35 and $4.11.

    Past 12 Months
    -17.0%
    -29.6%
    -38.3%
    -54.8%
    -42.1%
    -28.7%
    1W -$0.69
    1M -$1.41
    3M -$2.09
    6M -$4.07
    YTD -$2.44
    1Y -$1.35

    UNCY was -28.7% over the past year, -54.8% over six months, -42.1% year to date, -17.0% in the last week.

    12 Months vs Market
    UNCY
    -28.7%
    DIA
    +12.4%
    SPY
    +14.9%
    QQQ
    +17.5%
    IWM
    +11.1%

    Over the past 12 months UNCY returned -28.7% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

    Volume & Liquidity 1.30× 3-mo avg
    Today 1,102,300 3-mo avg 845.8K
    1W
    1.2M
    1M
    944.9K
    3M
    845.8K
    6M
    1.1M
    YTD
    930.0K
    1Y
    824.9K

    UNCY most recently traded 1,102,300 shares against a 3-month average daily volume of 845.8K.

    More News

    Read More
    News headline image
    Kaplan Fox Alerts Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 2, 2026
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    UNCY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Unicycive Therapeutics Securities Lawsuit - Contact SueWallSt
    From SueWallSt
    Via GlobeNewswire
    News headline image
    UNCY Shareholder Alert: November 2, 2026 Lead Plaintiff Deadline in Unicycive Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky
    From Levi & Korsinsky, LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox & Kilsheimer LLP Alerts Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to the Lead Plaintiff Deadline on November 2, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    UNCY Investor Alert: Unicycive Therapeutics, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
    From Levi & Korsinsky, LLP
    Via ACCESS Newswire
    News headline image
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    UNICYCIVE INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Unicycive Therapeutics, Inc. Investors with Large Losses to Contact the Firm Seeking Lead Plaintiff Role
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    UNCY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    UNCY Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Securities Class Action Against Unicycive Therapeutics, Inc.
    Via Newsfile
    Topics Lawsuit
    News headline image
    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY
    From Levi & Korsinsky, LLP
    Via ACCESS Newswire
    News headline image
    Kaplan Fox Class Action Reminder: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Lead Plaintiff Deadline is November 2, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Unicycive Therapeutics Appoints Meredith Manning to Board of Directors
    Via B2i Digital
    News headline image
    Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is November 2, 2026
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
    Via B2i Digital
    News headline image
    Kaplan Fox Deadline Alert: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors Have Until November 2, 2026 to Seek a Lead Plaintiff Role
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Deadline on November 2, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Robbins LLP Urges UNCY Stockholders Who Lost Money Investing in Unicycive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
    From Robbins LLP
    Via Business Wire
    News headline image
    Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm Before Lead Plaintiff Deadline on November 2, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to a Securities Class Action Deadline - Contact the Firm Before November 2, 2026
    Via NewMediaWire
    Topics Lawsuit

    Frequently Asked Questions

    Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?
    Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?
    The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market
    What is the current price of Unicycive Therapeutics, Inc. - Common Stock?
    The current price of Unicycive Therapeutics, Inc. - Common Stock is 3.360
    When was Unicycive Therapeutics, Inc. - Common Stock last traded?
    The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 10/16/26 04:00 PM ET
    What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?
    The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 48.75M
    How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?
    Unicycive Therapeutics, Inc. - Common Stock has 49M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.